Liaoning Chengda (China) Performance
688739 Stock | 27.25 0.16 0.59% |
Liaoning Chengda has a performance score of 1 on a scale of 0 to 100. The company secures a Beta (Market Risk) of -0.13, which conveys not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Liaoning Chengda are expected to decrease at a much lower rate. During the bear market, Liaoning Chengda is likely to outperform the market. Liaoning Chengda Bio right now secures a risk of 1.87%. Please verify Liaoning Chengda Biotechnology downside deviation, standard deviation, and the relationship between the semi deviation and coefficient of variation , to decide if Liaoning Chengda Biotechnology will be following its current price movements.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Liaoning Chengda Biotechnology are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Liaoning Chengda is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
Forward Dividend Yield 0.0294 | Payout Ratio 0.9877 | Forward Dividend Rate 0.8 | Ex Dividend Date 2024-06-20 |
1 | The controlling shareholder was changed to Yuemin Investment, and the new chairman of Liaoning Chengda talked about future planning - Yicai Global | 02/28/2025 |
Begin Period Cash Flow | 5.8 B |
Liaoning |
Liaoning Chengda Relative Risk vs. Return Landscape
If you would invest 2,700 in Liaoning Chengda Biotechnology on December 17, 2024 and sell it today you would earn a total of 25.00 from holding Liaoning Chengda Biotechnology or generate 0.93% return on investment over 90 days. Liaoning Chengda Biotechnology is generating 0.0328% of daily returns and assumes 1.8675% volatility on return distribution over the 90 days horizon. Simply put, 16% of stocks are less volatile than Liaoning, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
Risk |
Liaoning Chengda Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Liaoning Chengda's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Liaoning Chengda Biotechnology, and traders can use it to determine the average amount a Liaoning Chengda's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0176
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | 688739 |
Estimated Market Risk
1.87 actual daily | 16 84% of assets are more volatile |
Expected Return
0.03 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Liaoning Chengda is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Liaoning Chengda by adding it to a well-diversified portfolio.
Liaoning Chengda Fundamentals Growth
Liaoning Stock prices reflect investors' perceptions of the future prospects and financial health of Liaoning Chengda, and Liaoning Chengda fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Liaoning Stock performance.
Return On Equity | 0.0348 | ||||
Return On Asset | 0.0239 | ||||
Profit Margin | 0.20 % | ||||
Operating Margin | 0.01 % | ||||
Current Valuation | 6.01 B | ||||
Shares Outstanding | 416.45 M | ||||
Price To Book | 1.19 X | ||||
Price To Sales | 6.77 X | ||||
Revenue | 1.75 B | ||||
Gross Profit | 1.68 B | ||||
EBITDA | 515.07 M | ||||
Net Income | 465.92 M | ||||
Total Debt | 4.86 M | ||||
Book Value Per Share | 23.20 X | ||||
Cash Flow From Operations | 677.01 M | ||||
Earnings Per Share | 0.81 X | ||||
Total Asset | 10.08 B | ||||
Retained Earnings | 4.04 B | ||||
About Liaoning Chengda Performance
By analyzing Liaoning Chengda's fundamental ratios, stakeholders can gain valuable insights into Liaoning Chengda's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Liaoning Chengda has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Liaoning Chengda has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Liaoning Chengda is entity of China. It is traded as Stock on SHG exchange.Things to note about Liaoning Chengda Bio performance evaluation
Checking the ongoing alerts about Liaoning Chengda for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Liaoning Chengda Bio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Liaoning Chengda Bio is unlikely to experience financial distress in the next 2 years | |
About 60.0% of the company shares are owned by insiders or employees | |
Latest headline from news.google.com: The controlling shareholder was changed to Yuemin Investment, and the new chairman of Liaoning Chengda talked about future planning - Yicai Global |
- Analyzing Liaoning Chengda's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Liaoning Chengda's stock is overvalued or undervalued compared to its peers.
- Examining Liaoning Chengda's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Liaoning Chengda's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Liaoning Chengda's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Liaoning Chengda's stock. These opinions can provide insight into Liaoning Chengda's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Liaoning Stock analysis
When running Liaoning Chengda's price analysis, check to measure Liaoning Chengda's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Liaoning Chengda is operating at the current time. Most of Liaoning Chengda's value examination focuses on studying past and present price action to predict the probability of Liaoning Chengda's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Liaoning Chengda's price. Additionally, you may evaluate how the addition of Liaoning Chengda to your portfolios can decrease your overall portfolio volatility.
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |